IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GHADA O AL-ASADI

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1598875239
CMS profile
254065
Location
DIAMOND BAR, CA

General Payments · PY2018–2024

$9,628.05

  • Reported across 470 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,181.80

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,181.80 51

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Vanda Pharmaceuticals Inc. $325.08 11
ITI, Inc. $267.42 13
Lundbeck LLC $119.77 6
ABBVIE INC. $102.99 5
Janssen Pharmaceuticals, Inc $53.43 2
Almatica Pharma Inc. $53.03 2
E.R. Squibb & Sons, L.L.C. $50.09 2
Otsuka America Pharmaceutical, Inc. $49.85 2
Alkermes, Inc. $43.44 2
IDORSIA PHARMACEUTICALS US INC $31.62 2
Takeda Pharmaceuticals U.S.A., Inc. $31.45 2
Axsome Therapeutics, Inc. $27.87 1
Teva Pharmaceuticals USA, Inc. $25.76 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $334.39 21
PY2019 $774.74 46
PY2020 $836.94 42
PY2021 $2,218.59 112
PY2022 $1,991.15 93
PY2023 $2,290.44 105
PY2024 $1,181.80 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $26.16 05/16/2024 Food and Beverage Undisputed 01/23/2026 1103194208 CMS
ABBVIE INC. $19.51 07/17/2024 Food and Beverage Undisputed 01/23/2026 1103194210 CMS
ABBVIE INC. $18.67 08/27/2024 Food and Beverage Undisputed 01/23/2026 1103194212 CMS
ABBVIE INC. $19.31 09/04/2024 Food and Beverage Undisputed 01/23/2026 1103194214 CMS
ABBVIE INC. $19.34 12/05/2024 Food and Beverage Undisputed 01/23/2026 1103194216 CMS
Alkermes, Inc. $28.77 05/01/2024 Food and Beverage Undisputed 01/23/2026 1120455646 CMS
Alkermes, Inc. $14.67 06/13/2024 Food and Beverage Undisputed 01/23/2026 1120455648 CMS
Almatica Pharma LLC $24.35 05/07/2024 Food and Beverage Undisputed 01/23/2026 1137554627 CMS
Almatica Pharma LLC $28.68 09/25/2024 Food and Beverage Undisputed 01/23/2026 1137554631 CMS
Axsome Therapeutics, Inc. $27.87 10/17/2024 Food and Beverage Undisputed 01/23/2026 1148282279 CMS
E.R. Squibb & Sons, L.L.C. $32.38 10/10/2024 Food and Beverage Undisputed 01/23/2026 1101680209 CMS
E.R. Squibb & Sons, L.L.C. $17.71 11/25/2024 Food and Beverage Undisputed 01/23/2026 1101680242 CMS
IDORSIA PHARMACEUTICALS US INC $15.80 06/11/2024 Food and Beverage Undisputed 01/23/2026 1146756451 CMS
IDORSIA PHARMACEUTICALS US INC $15.82 10/02/2024 Food and Beverage Undisputed 01/23/2026 1146757766 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.69 04/01/2024 Food and Beverage Undisputed 01/23/2026 1143181876 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.72 05/07/2024 Food and Beverage Undisputed 01/23/2026 1143181880 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.41 06/06/2024 Food and Beverage Undisputed 01/23/2026 1143181884 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $30.18 06/12/2024 Food and Beverage Undisputed 01/23/2026 1143181887 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.16 06/13/2024 Food and Beverage Undisputed 01/23/2026 1143181891 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.21 07/02/2024 Food and Beverage Undisputed 01/23/2026 1143181895 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $30.39 08/07/2024 Food and Beverage Undisputed 01/23/2026 1143181899 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1.70 08/20/2024 Food and Beverage Undisputed 01/23/2026 1143181903 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.35 08/20/2024 Food and Beverage Undisputed 01/23/2026 1143181906 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.76 08/21/2024 Food and Beverage Undisputed 01/23/2026 1143181910 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $34.69 09/05/2024 Food and Beverage Undisputed 01/23/2026 1143181913 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.18 10/08/2024 Food and Beverage Undisputed 01/23/2026 1143181917 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.98 10/09/2024 Food and Beverage Undisputed 01/23/2026 1143181921 CMS
Janssen Pharmaceuticals, Inc $27.18 03/07/2024 Food and Beverage Undisputed 01/23/2026 1077925397 CMS
Janssen Pharmaceuticals, Inc $26.25 09/12/2024 Food and Beverage Undisputed 01/23/2026 1077925197 CMS
Lundbeck LLC $23.74 04/16/2024 Food and Beverage Undisputed 01/23/2026 1145890083 CMS
Lundbeck LLC $22.99 08/01/2024 Food and Beverage Undisputed 01/23/2026 1145890085 CMS
Lundbeck LLC $14.64 10/04/2024 Food and Beverage Undisputed 01/23/2026 1145890087 CMS
Lundbeck LLC $20.62 11/06/2024 Food and Beverage Undisputed 01/23/2026 1145890089 CMS
Lundbeck LLC $16.15 11/08/2024 Food and Beverage Undisputed 01/23/2026 1145890091 CMS
Lundbeck LLC $21.63 11/21/2024 Food and Beverage Undisputed 01/23/2026 1145890093 CMS
Otsuka America Pharmaceutical, Inc. $21.75 10/24/2024 Food and Beverage Undisputed 01/23/2026 1118850238 CMS
Otsuka America Pharmaceutical, Inc. $28.10 11/13/2024 Food and Beverage Undisputed 01/23/2026 1118850240 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.94 10/31/2024 Food and Beverage Undisputed 01/23/2026 1137465985 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.51 12/04/2024 Food and Beverage Undisputed 01/23/2026 1137465988 CMS
Teva Pharmaceuticals USA, Inc. $25.76 09/19/2024 Food and Beverage Undisputed 01/23/2026 1151598761 CMS
Vanda Pharmaceuticals Inc. $32.21 03/12/2024 Food and Beverage Undisputed 01/23/2026 1133894343 CMS
Vanda Pharmaceuticals Inc. $37.27 04/04/2024 Food and Beverage Undisputed 01/23/2026 1133894345 CMS
Vanda Pharmaceuticals Inc. $38.32 04/10/2024 Food and Beverage Undisputed 01/23/2026 1133894347 CMS
Vanda Pharmaceuticals Inc. $39.59 04/24/2024 Food and Beverage Undisputed 01/23/2026 1133894349 CMS
Vanda Pharmaceuticals Inc. $10.75 05/10/2024 Food and Beverage Undisputed 01/23/2026 1133894351 CMS
Vanda Pharmaceuticals Inc. $34.28 06/06/2024 Food and Beverage Undisputed 01/23/2026 1133894353 CMS
Vanda Pharmaceuticals Inc. $37.03 08/08/2024 Food and Beverage Undisputed 01/23/2026 1133894355 CMS
Vanda Pharmaceuticals Inc. $37.61 08/22/2024 Food and Beverage Undisputed 01/23/2026 1133894357 CMS
Vanda Pharmaceuticals Inc. $28.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 1133894359 CMS
Vanda Pharmaceuticals Inc. $26.89 11/20/2024 Food and Beverage Undisputed 01/23/2026 1133894361 CMS
Vanda Pharmaceuticals Inc. $3.13 11/20/2024 Food and Beverage Undisputed 01/23/2026 1133894363 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.